Live Breaking News & Updates on Standard market

Stay updated with breaking news from Standard market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

LA JOLLA, Calif., May 20, 2024 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange , today announced that it has...

Tokyo , Japan , Kazuko-matsuda , Davidh-crean , Trademark-office , Nasdaq , Medicinova-inc , Uveal-melanoma-in-molecular-cancer-research , Exchange-commission , Standard-market , Tokyo-stock-exchange , Code-number

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo , Japan , Davidh-crean , Kazuko-matsuda , Nasdaq , Uveal-melanoma-in-molecular-cancer-research , Medicinova-inc , Exchange-commission , Trademark-office , Nova-receives-notice , New-patent-covering , Standard-market

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tokyo , Japan , Kazuko-matsuda , Davidh-crean , Trademark-office , Exchange-commission , Nasdaq , Medicinova-inc , Standard-market , Tokyo-stock-exchange , Code-number , Chief-medical-officer

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo , Japan , Davidh-crean , Kazuko-matsuda , Trademark-office , Medicinova-inc , Nasdaq , Exchange-commission , Nova-receives-notice , New-patent-covering , Chlorine-induced-acute-respiratory-distress , Standard-market

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome - MediciNova (NASDAQ:MNOV)

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome - MediciNova (NASDAQ:MNOV)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Tokyo , Japan , Davidh-crean , Kazuko-matsuda , Medicinova-inc , Trademark-office , Exchange-commission , Nasdaq , Standard-market , Tokyo-stock-exchange , Code-number , Chief-medical-officer

Nomura : Senior Managing Director - Form 6-K

Nomura : Senior Managing Director - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , Chuo-ku , Tokyo , Japan , Blackrock , Eastern-cape , South-africa , Nagoya , Aichi , Washington , United-states , In-nomura

Gala Incorporated : Matters Concerning Controlling Shareholders etc.

NOTE: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese...

Japan , Japanese , Yuki-okamoto , Hyungwoo-chon , Hyunsu-kim , Gala-inc , Company-name , Megazone-cloud-corporation , Megazone-group , Megazone-corporation , Standard-market , Concerning-controlling-shareholders

Form 424B2 ROYAL BANK OF CANADA

Form 424B2 ROYAL BANK OF CANADA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Spain , Germany , London , City-of , United-kingdom , Belgium , Italy , Tokyo , Japan , Switzerland , France

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) - MediciNova (NASDAQ:MNOV)

LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number:

Tokyo , Japan , Chicago , Illinois , United-states , American , Geoff-obrien , Gilbert-youssef , Oncology-at-dana-farber-cancer-institute , American-society-of-clinical-oncology , Exchange-commission , Nasdaq

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)

LA JOLLA, Calif., April 02, 2024 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange , today announced that an...

Chicago , Illinois , United-states , Tokyo , Japan , American , Gilbert-youssef , Geoff-obrien , Nasdaq , Exchange-commission , Physician-at-harvard-medical-school , Medicinova-inc